All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY2444 | Anti-MTDH (CBFYM-2727) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2727 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2445 | Anti-MTDH (CBFYM-2728) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2728 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2446 | Anti-MTDH (CBFYM-2729) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse | CBFYM-2729 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2447 | Anti-MTDH (CBFYM-2730) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYM-2730 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5697 | Anti-MTDH (CBFYM-2727) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2727 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5698 | Anti-MTDH (CBFYM-2728) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2728 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5699 | Anti-MTDH (CBFYM-2729) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse | CBFYM-2729 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5700 | Anti-MTDH (CBFYM-2730) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | CBFYM-2730 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ010 | Anti-MTDH (2F11C3) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2F11C3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ510 | Anti-MTDH (2F11C3) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2F11C3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION